ABSTRACT Salmonella enterica is an intracellular pathogen that causes diseases ranging from gastroenteritis to typhoid fever. Salmonella bacteria trigger an autophagic response in host cells upon infection but have evolved mechanisms for suppressing this response, thereby enhancing intracellular survival. We recently reported that S. enterica serovar Typhimurium actively recruits the host tyrosine kinase focal adhesion kinase (FAK) to the surface of the Salmonella-containing vacuole ( 
in the cytoplasm (13) . Loss of essential autophagy components, such as autophagy protein 5 (Atg5), results in the unrestricted growth of Salmonella in fibroblasts in vitro (14) . In addition, mice harboring intestinal epithelial cell-specific deletions of the autophagy protein Atg16L1 or Atg5 are more susceptible to Salmonella infection in vivo (15, 16) .
Many intracellular pathogens have evolved strategies that antagonize autophagy initiation, evade autophagic recognition, or use components of the autophagy system to facilitate intracellular growth (17) (18) (19) . Indeed, we have shown previously that the SPI-2 which encoded T3SS-2, which is upregulated upon internalization of Salmonella by host cells, mediates active suppression of autophagic signaling in macrophages (20) . S. Typhimurium specifically activates the host molecule focal adhesion kinase (FAK), which is recruited to SCVs in a T3SS-2-dependent manner. FAK then triggers activation of the Akt-mTORC1 signaling axis, resulting in downregulation of the autophagic response. Importantly, FAK-deficient macrophages fail to activate Akt-mTORC1 signaling, leading to more efficient autophagic capture of Salmonella and reduced bacterial survival.
The induction of antimicrobial autophagy acts in conjunction with other innate immune pathways, including type I interferon (IFN) production, inflammasome signaling, and signaling of retinoic acid-inducible gene I (RIG-I)-like helicase receptors (RLRs) (21) . Type I interferons (alpha interferon [IFN-␣] subtypes, IFN-␤, and IFN-) are pleiotropic cytokines that induce antiviral, antiproliferative, and immunomodulatory effects in cells. Previous studies have determined that autophagy is involved in both the positive and negative regulation of these cytokines. For example, in plasmacytoid dendritic cells (pDCs), autophagy inhibition suppresses viral recognition and the induction of type I IFNs (22, 23) . In contrast, Atg5-deficient mouse embryonic fibroblasts (MEFs) were found to be resistant to viral replication, and this was attributed to the hyperproduction of type I interferons in response to immunostimulatory RNA (24) . Atg9 has also recently been reported to downregulate interferon-stimulatory DNA (ISD)-mediated type I IFN production in MEFs (25) . Thus, autophagy genes can positively or negatively regulate type I IFN signaling in a cell type-dependent and stimulus-dependent manner, and in some cases this involves noncanonical roles of Atg genes.
Although it is well established that the type I IFN response to viral infection is protective, its role in containing bacterial infections is less well understood and may be pathogen specific. In some cases, the IFN response is beneficial to the host (26, 27) , while it has been shown in other cases to impair bacterial clearance (28) . Here we show that the ability of Salmonella to suppress the autophagic response also results in suppression of the induction of IFN-␤ in macrophages. In contrast, autophagic capture of Salmonella enhances IFN-␤ production through a mechanism that requires endosomal Toll-like receptor 3 (TLR3) and TLR4 but not the cytosolic nucleotide sensor cGAS/stimulator of IFN genes (STING) or MDA-5/RIG-I. After oral infection, bacterial suppression of autophagy limits local interferon production, leading to efficient colonization and systemic dissemination. If autophagy is not suppressed (i.e., in the absence of FAK), colonization is attenuated, in a manner that is dependent on mucosal IFN-␤ production by macrophages and the coordinated secretion of IFN-␥ by NK cells in vivo.
RESULTS
Autophagy enhances production of IFN-␤ in Salmonellainfected macrophages. While intracellular Salmonella bacteria are largely contained within the SCV in epithelia, the SPI-1 invasion machinery has been shown to perforate the SCV membrane, allowing recognition of bacteria by cytosolic pattern recognition receptors (PRRs). However, the majority of invasion-associated genes are downregulated after entry into host cells (4, 29, 30) , and it is likely that Salmonella bacteria that have penetrated the intestinal epithelium are captured passively by mucosal macrophages. To mimic this process, in vitro experiments were performed with a mutant of S. Typhimurium strain SL1344 that lacks a functional SPI-1 T3SS (the ⌬invG mutant).
Many intracellular pathogens induce expression of type I interferons (IFN-␣/␤) through recognition of bacterial pathogenassociated molecular patterns (PAMPs) by pattern recognition receptors located at the cell surface and in the cytosol (31) (32) (33) (34) ; for a review, see reference 35). For example, it is well established that lipopolysaccharide (LPS) stimulation of macrophages results in the production of IFN-␤ (36) . In accordance with this, we observed a 10-fold increase in IFN-␤ transcription upon treatment of wild-type (WT) mouse peritoneal macrophages (PEMs) with Salmonella LPS (Fig. 1A) . Interestingly, however, WT macrophages incubated with noninvasive (⌬invG) S. Typhimurium for 5 h failed to upregulate IFN-␤ despite the presence of LPS, suggesting that Salmonella bacteria are capable of repressing this response (Fig. 1A) .
We showed previously that S. Typhimurium is also able to suppress autophagy in macrophages by recruiting FAK to the cytoplasmic face of the SCV, where it stimulates the Akt/mTORC1 signaling pathway (20) . If this suppressive mechanism is not operational (i.e., in the absence of FAK), macrophages mount a robust autophagic response to intracellular Salmonella that results in efficient bacterial clearance (see Fig. S1A in the supplemental material) (20) . Since autophagy plays a major role in the biogenesis and secretion of cytokines, including type I interferons, we next examined whether enhanced autophagy could alleviate Salmonella-induced suppression of the type I IFN response. PEMs derived from WT or FAK Ϫ/Ϫ mice were incubated with noninvasive (⌬invG) S. Typhimurium for 5 h, after which IFN-␤ and IFN-␣ mRNA levels were evaluated by quantitative PCR (qPCR). As shown in Fig. 1B , infection induced a significant increase in levels of IFN-␤, but not IFN-␣, in FAK Ϫ/Ϫ PEMs compared to WT controls, with similar results observed in FAK-depleted primary immortalized macrophages (iMacs) (WT bone marrow-derived macrophages [BMDMs]) (see Fig. S1B and C). The transcriptional upregulation of IFN-␤ levels observed in Salmonellainfected FAK Ϫ/Ϫ PEMs correlated with a proportional increase in IFN-␤ protein expression ( Fig. 1C and D) .
The interferon response factors (IRFs) are critical regulators of the type I IFN response. While both IRF-3 and IRF-7 are activated downstream of similar signaling pathways involving TRAF3 and TRAF6, activation of IRF-3 induces transcription of IFN-␤, whereas activation of IRF-7 preferentially stimulates IFN-␣ (37, 38) . In contrast to WT PEMs, infection of FAK-deficient macrophages triggered robust activation of the IRF-3-activating kinase TBK1 and a corresponding increase in IRF-3 phosphorylation (Fig. 1E) . Consistent with the absence of IFN-␣ induction, infection failed to activate IRF-7 in either WT or FAK Ϫ/Ϫ macrophages (see Fig. S1D in the supplemental material). To confirm the involvement of IRF-3 in the induction of IFN-␤, small interfering RNA (siRNA)-mediated depletion of IRF-3 from FAK Ϫ/Ϫ macrophages resulted in a significant decrease in IFN-␤ mRNA levels compared to control cell results during infection (Fig. 1F) . Together, these results suggest that the autophagic capture of intracellular Salmonella increases the production of IFN-␤ by enhancing signaling through the TBK1/IRF3 pathway.
A weak IFN-␤ response in Salmonella-infected macrophages is amplified by autophagy. We next addressed whether the Salmonella-mediated induction of IFN-␤ expression observed in FAK Ϫ/Ϫ macrophages was dependent on autophagy. As shown in Fig. 2A , treatment of uninfected macrophages with the autophagy-inducing agent rapamycin (sirolimus) did not result in the activation of TBK1 or IRF-3, indicating that autophagy in the absence of bacteria is not sufficient to drive this pathway. However, the activation of both TBK1 and IRF-3 was significantly enhanced following rapamycin treatment in WT macrophages infected with Salmonella ( Fig. 2A) , and this was coincident with elevated IFN-␤ mRNA expression (Fig. 2B) . As expected, Salmonella infection alone induced robust TBK-1 and IRF-3 phosphorylation in FAK Ϫ/Ϫ macrophages which did not increase further in the presence of rapamycin ( Fig. 2A) . To confirm that this response was dependent upon autophagy, FAK Ϫ/Ϫ macrophages were depleted of the essential autophagy component Atg5, which strongly inhibited both IRF-3 activation and IFN-␤ induction ( Fig. 2C and   D) . Similarly, treatment of FAK Ϫ/Ϫ cells with the autophagy inhibitor 3-methyladenine (3-MA) also significantly reduced IFN-␤ expression (Fig. 2E) . Together, these data show that pathogen stimulation is required to trigger the TBK1-IRF-3-IFN-␤ pathway and that this response is enhanced under autophagypromoting conditions. TRIF mediates IFN-␤ induction in FAK ؊/؊ macrophages following Salmonella infection. FAK deficiency promotes both the autophagic capture of Salmonella (see Fig. S1A in the supplemental material) (20) and the subsequent induction of IFN-␤ during infection (Fig. 1) . However, it remained unclear how pathogen-mediated autophagy triggers the interferon response. We reasoned that autophagy may represent an important means through which bacterial products are delivered to intracellular pattern recognition receptors, ultimately leading to IFN-␤ production.
We had shown previously that nearly all (85% to 95%) internalized ⌬invG Salmonella bacteria in macrophages are contained within undamaged SCVs, making it unlikely that recognition occurs directly in the cytosol (20) . This is also consistent with the fact that we found no evidence of inflammasome activation in either WT or FAK-deficient macrophages (as determined by caspase-1 cleavage) after incubation with noninvasive Salmonella (see Fig. S2A in the supplemental material). Nonetheless, to test whether cytosolic nucleic acid sensors are involved in upregulating IFN-␤, we examined IRF-3 activation and IFN-␤ levels in Small interfering control (siCont.) and siIRF-3-treated FAK Ϫ/Ϫ macrophages were incubated for 5 h with the S. Typhimurium ⌬invG strain, and levels of IFN-␤ mRNA in infected cells were calculated relative to those seen with uninfected controls. *, P Ͻ 0.05; n ϭ 3. Statistical significance was determined using a Student's t test; error bars represent standard errors of the means (SEM). Densitometry was calculated using ImageJ. macrophages derived from mice lacking mitochondrial antiviral signaling (MAVS) or in cells depleted of STING. MAVS is an adapter molecule that couples the double-stranded RNA (dsRNA) recognition molecules RIG-I and MDA5 to IFN-␤ induction (39) , whereas STING functions downstream of cytoplasmic DNA sensors to induce IFN-␤ (40) . The loss of MAVS failed to inhibit autophagy-driven IRF-3 activation or the induction of IFN-␤, regardless of whether autophagy was induced by rapamycin treatment (see Fig. S2B and C) or FAK depletion (see Fig. S2D and E). Similarly, STING depletion in autophagic FAK Ϫ/Ϫ macrophages failed to suppress IFN-␤ levels upon incubation with Salmonella (see Fig. S2F ). Importantly, neither the loss of MAVS nor depletion of STING inhibited bacterial internalization (see Fig. S2G ) or the autophagic capture of bacteria (see Fig. S2H ). Together, these data indicate that nucleic acids derived from ⌬invG Salmonella are not detected by cytosolic PRRs under autophagic conditions.
Similarly to the RLRs and STING, endosomal Toll-like receptors (TLRs) recognize microbial nucleic acids but signal via the adaptor molecules MyD88 or TRIF to initiate type I IFN responses. In contrast to MAVS-and STING-deficient cells, we found that IRF-3 activation and IFN-␤ induction were completely abolished in cells lacking both MyD88 and TRIF, regardless of whether autophagy was induced by rapamycin treatment (Fig. 3A and C) or FAK depletion ( Fig. 3B and C) . Again, differences in IRF-3 signaling and IFN-␤ levels were not the result of altered bacterial uptake, as MyD88/TRIF knockout macrophages internalized the same number of bacteria as WT control cells (see Fig. S2G in the supplemental material).
To determine whether MyD88 or TRIF is responsible for the upregulation of IFN-␤, WT macrophages depleted of either protein individually were treated with rapamycin before infection with Salmonella. As shown in Fig. 3D and E, depletion of TRIF but not MyD88 resulted in reduced IRF-3 activation and IFN-␤ induction. Similarly, FAK Ϫ/Ϫ macrophages depleted of TRIF ( Fig. 3F and H ) also failed to induce IRF-3 activation or IFN-␤ transcription compared to MyD88-depleted FAK Ϫ/Ϫ macrophages ( Fig. 3G and H) .
To examine whether TRIF-mediated signaling is critical for the efficient elimination of Salmonella, FAK Ϫ/Ϫ macrophages depleted of TRIF were incubated with ⌬invG Salmonella for 3 h before bacterial survival was assessed. We found that TRIF depletion promoted bacterial survival and proliferation compared to control cell results (Fig. 3I ). In contrast, stimulation of the TRIF pathway with poly(I:C), a dsRNA analog that functions as a potent TLR3 agonist and inducer of IFN-␤, in WT macrophages resulted in a significant decrease in bacterial survival (Fig. 3J) . Together, these data confirm that TRIF, rather than MyD88, is required for the autophagy-mediated enhancement of IFN-␤ production.
The IFN-␤ response to autophagic killing of Salmonella is mediated by both TLR3 and TLR4. We next examined whether the induction of IFN-␤ was dependent on the activity of TLR3 and/or TLR4, as these are the only intracellular TLRs that utilize TRIF for downstream signaling. To do this, TLR4-deficient macrophages were treated with rapamycin before incubation with bacteria. We found that while macrophages lacking TLR4 internalized the same number of bacteria as control macrophages (see Fig. S2G in the supplemental material), they failed to activate IRF-3 or induce IFN-␤ whether autophagy was induced with rapamycin or not ( Fig. 4A and C) . Similar results were observed in TLR4 Ϫ/Ϫ macrophages depleted of FAK ( Fig. 4B and C). Addi- tionally, depletion of TLR3 from either rapamycin-treated WT cells ( Fig. 4D and E) or FAK Ϫ/Ϫ macrophages ( Fig. 4F and G) resulted in a significant reduction in both IRF-3 activation and IFN-␤ induction after Salmonella infection. To further confirm the role of TLR3, which requires endosomal processing for efficient ligand recognition (41), FAK Ϫ/Ϫ macrophages were treated with bafilomycin A1 to inhibit endosome/lysosome protease activity before incubation with Salmonella. As shown in Fig. 4G , treatment of cells with bafilomycin A1 strongly inhibited the induction of IFN-␤. Together, these data suggest a model whereby autophagic capture of bacteria promotes bacterial degradation and the delivery of microbial products to endosomal compartments containing TLR3 and TLR4, ultimately leading to the induction of IFN-␤ (Fig. 4H) .
FAK is required for Salmonella-induced suppression of the IFN response in vivo. Since FAK deletion in conditional FAK knockout (FAK ⌬myeloid ) animals is restricted to macrophages (see Fig. S3A to D in the supplemental material), we can use this animal model to determine if macrophage-mediated autophagy enhances the type I IFN response to Salmonella in vivo.
To first examine the role of FAK in the macrophage response to Salmonella infection, WT and FAK ⌬myeloid mice were orally inoculated with fully virulent S. Typhimurium (strain SL1344) and tissue colonization was examined. At 2 days postinfection, we did FIGURE 3 IFN-␤ production in response to Salmonella infection requires TRIF. (A and B) Immortalized macrophages (iMacs) deficient in both MyD88 and TRIF (MyD88 Ϫ/Ϫ /TRIF Ϫ/Ϫ ) were pretreated with rapamycin (1 nM) for 1 h (A) or were depleted of FAK by siRNA before incubation with ⌬invG Salmonella (B) (MOI, 100) for 5 h. Lysates were immunoblotted with the indicated antibodies; n ϭ 3. (C) Macrophages were treated as described for panels A and B before assessment of IFN-␤ mRNA levels. IFN-␤ amounts in infected cells were calculated relative to those seen with uninfected controls. n.s., not significant; n ϭ 3. (D) WT iMacs were depleted of TRIF or MyD88 before pretreatment with rapamycin (1 nM) for 1 h prior to infection with ⌬InvG Salmonella for 5 h. Lysates were immunoblotted with the indicated antibodies; n ϭ 3. (E) Macrophages were treated as described for panel D before assessment of IFN-␤ mRNA levels. IFN-␤ amounts in infected cells were calculated relative to those seen with uninfected controls. *, P Ͻ 0.05; n.s., not significant; n ϭ 3. (F and G) FAK Ϫ/Ϫ macrophages were depleted of TRIF or MyD88 before infection with ⌬invG Salmonella (MOI, 100) for 5 h. Lysates were then immunoblotted with the indicated antibodies; n ϭ 3. In panel G, MyD88 knockdown efficiency was determined by assessing MyD88 mRNA levels relative to those seen with siCont.-treated cells. (H) FAK Ϫ/Ϫ macrophages were treated as described for panel F and G before measurement of IFN-␤ mRNA levels. IFN-␤ amounts in infected cells were calculated relative to those seen with uninfected controls. *, P Ͻ 0.05; n ϭ 3. (I) FAK Ϫ/Ϫ macrophages depleted of TRIF were incubated with the S. Typhimurium ⌬invG strain fornot detect differences in bacterial loads recovered from the Peyer's patches (PPs) of WT and FAK ⌬myeloid mice (Fig. 5A) ; nor did we see differences between genotypes in levels of fecal bacterial shedding (see Fig. S3E in the supplemental material), indicating that bacterial invasion through the intestinal epithelium was not altered by FAK deficiency in macrophages. However, bacterial burdens were 20-fold higher in the ileum, 5-fold higher in the ceca, and 10-fold higher in the mesenteric lymph nodes (mLNs) of WT mice than in those of FAK ⌬myeloid littermates (Fig. 5A ). This is consistent with our previous observations showing that loss of FAK from macrophages also limits the dissemination of bacteria to more distal sites such as the liver and spleen (20) .
Given the upregulation in the Salmonella-driven IFN-␤ response that we observed in FAK-deficient macrophages, we next examined the ability of mice to mount a local innate immune response in the small intestine after oral infection. Using flow cytometric analysis of intracellular cytokines, we observed a significant increase in the overall proportion of IFN-␤-expressing cells in the lamina propria (LP) of FAK ⌬myeloid mice compared to WT mice ( Fig. 5B ; see also Fig. S4A in the supplemental material). Among these IFN-␤-producing cells, 50% to 60% were F4-80 ϩ CD11c lo macrophages whereas a smaller proportion were F4-80 ϩ CD11c ϩ , a phenotype attributed to myeloid dendritic cells (DCs) (42) (Fig. 5B) . We also examined IRF-3 activity in lamina propria lysates harvested from WT and FAK ⌬myeloid mice 2 days postinfection. Similarly to our results from infected macrophages in vitro, phospho-IRF-3 levels were low in WT mice but were elevated 8-fold in FAK ⌬myeloid mice. This is consistent with the increased number of IFN-␤-producing cells in these animals (Fig. 5C ).
An important consequence of IFN-␤ production by infected macrophages is the ability of this cytokine to stimulate the production of IFN-␥ by bystander cells (43) . To determine if the elevated levels of IFN-␤ in the LP of FAK ⌬myeloid mice correlated with increased IFN-␥, we next measured levels of this cytokine in Lysates were then immunoblotted with the indicated antibodies; n ϭ 3. (C) IFN-␤ mRNA levels in cells treated as described for panels A and B were calculated relative to those seen with uninfected controls. n.s., not significant; n ϭ 3. (D) WT iMacs depleted of TLR3 were pretreated for 1 h with rapamycin (1 nM) before infection with ⌬invG Salmonella (MOI, 100) for 5 h. Lysates were then immunoblotted with the indicated antibodies; n ϭ 3. TLR3 knockdown efficiency was determined by assessing TLR3 mRNA levels relative to those seen with siCont.-treated cells. (E) IFN-␤ mRNA levels in cells treated as described for panel D were calculated relative to those seen with uninfected controls. *, P Ͻ 0.05; n ϭ 3. (F) FAK Ϫ/Ϫ macrophages were depleted of TLR3 before infection with ⌬invG Salmonella (MOI, 100) for 5 h. Lysates were then immunoblotted with the indicated antibodies; n ϭ 3. (G) FAK Ϫ/Ϫ macrophages were either treated as described for panel F or pretreated with bafilomycin A1 (Baf.A1) (100 nM) for 1 h before infection for 5 h with the S. Typhimurium ⌬invG strain. IFN-␤ mRNA levels in infected cells were calculated relative to those seen with uninfected controls. *, P Ͻ 0.05; n ϭ 3. Statistical significance was determined using a Student's t test; error bars represent SEM. (H) Model showing that autophagic conditions (FAK deletion or sirolimus treatment) promote the delivery of antigenic material to TLR-containing endosomes, resulting in IFN-␤ upregulation. Inhibition at each step (step 1, autophagosomes; step 2, autolysosomes; steps 3 and 4, TLR signaling; step 5, TRIF/IRF3 signaling) suppresses IFN-␤. PM, plasma membrane; SCV, Salmonella-containing vacuole; Ly, lysosome. Immunoblots represent results of one of three independent experiments. Densitometry was calculated using ImageJ. Unless indicated otherwise, statistical significance was determined using a Student's t test; error bars represent SEM.
WT and FAK-deficient mice 2 days after oral infection. IFN-␥ levels were not significantly higher in WT mice than in control, noninfected mice (Fig. 5D) . In contrast, relative IFN-␥ levels in the LP increased 5-fold in FAK-deficient mice (Fig. 5D ). This was correlated with a quantitatively similar increase in the levels of IFN-␥-producing cells present in the LP of FAK-deficient mice compared to WT littermates ( Fig. 5E and F ; see also Fig. S4B in the  supplemental material) .
NK cells are an important first source of IFN-␥ (43). In agreement with these findings, we observed that approximately 70% of the IFN-␥-producing cells were CD3-negative, NK1.1-positive NK cells (Fig. 5E ). This did not reflect enhanced recruitment of these cells, as the overall percentages of lamina propria NK cells remained equivalent in naive and infected animals (see Table S1 in the supplemental material). Examination of activated signal transducer and activator of transcription 1 (STAT1) levels in LP lysates revealed 30-fold induction of phospho-STAT1 in FAK-deficient mice 2 days postinfection (Fig. 5G) (44) . Upon oral infection with WT Salmonella strain SL1344, mice that received the anti-IFNAR1 antibody exhibited a striking 100-fold increase in colonization of the ileum and a nearly 10-fold increase in bacterial burden in the mesenteric lymph nodes (mLNs) (Fig. 6A) . Furthermore, we found that blocking IFN-␤ signaling partially blocked the expression of IFN-␥ in the ileum of FAK-deficient mice at 48 h postinfection (Fig. 6B) . To test whether the elevated level of IFN-␥ observed in FAK ⌬myeloid animals (Fig. 5 ) also plays a protective role during infection, FAKdeficient animals were treated with either control IgG or neutralizing anti-IFN-␥ antibodies (45) before infection with WT S. Typhimurium. As shown in Fig. 6A , bacterial loads in both the ileum and mLNs were significantly higher in mice treated with anti-IFN-␥ antibodies than in animals receiving IgG.
Given that IFN-␤ is critical for protection against Salmonella dissemination, we next examined whether stimulation of this pathway would provide protection against infection. Control WT mice were injected intraperitoneally (i.p.) with 100 g of IgG 1 day prior (day Ϫ1) to infection with WT S. Typhimurium, while animals in a second cohort were treated with 100 g of poly(I:C) on day Ϫ1 or received poly(I:C) in addition to the anti-IFNAR1 antibody before oral infection. At 2 days postinfection, we observed a significant reduction in the bacterial burdens recovered from the small intestines of poly(I:C)-treated animals compared to control IgG-treated mice which was lost in animals receiving both poly(I:C) and anti-IFNAR1 (Fig. 6C) . To further examine the protective effect of poly(I:C) treatment, WT mice were left untreated (-Tx) or administered poly(I:C) before oral inoculation with a lower, albeit lethal dose (10 8 CFU/mouse) of S. Typhimurium, and the clinical course of disease was followed until 10 days postinfection. Although all animals, regardless of treatment, eventually succumbed to infection, the mortality rate of poly(I:C)-treated animals was significantly lower than that of untreated control mice (7 versus 9 days) (Fig. 6D) . In addition, mice receiving poly(I:C) were better able to retain weight (Fig. 6E) and exhibited significantly reduced disease activity (Fig. 6F ) compared to animals receiving infection alone.
Bacterial activation of FAK suppresses the early innate immune response to S. Typhimurium in mLNs. CXCL9/MIG and CXCL10/IP-10 are members of the CXC class of IFN-inducible chemokines that function as potent chemoattractants for phagocytes, including neutrophils and inflammatory monocytes (46) . Consistent with the upregulation in both IFN-␤-and IFN-␥-expressing cells observed in Salmonella-infected FAK ⌬myeloid mice (Fig. 5) , we saw a significant induction of IFN-␥, CXCL9, and CXCL10 in mLN cell lysates harvested from FAK-deficient mice relative to WT controls (Fig. 7A) . Furthermore, flow cytometric analysis of myeloid populations in the mLNs showed a significantly higher percentage of activated Ly6G hi neutrophils (Fig. 7B and C, region 1 [R1]; see also Fig. S4C in the supplemental material) recruited to these tissues in FAK ⌬myeloid animals than in control mice, whereas levels of Ly6C hi inflammatory monocyte infiltration (region 2 [R2]) were equivalent between genotypes. Recently, Burton et al. (2014) determined that neutrophils were critical for limiting the spread of Salmonella within inflammatory lesions (47) . To confirm the importance of neutrophils for Salmonella clearance, WT and FAK ⌬myleoid animals were treated with either IgG control antibodies or anti-Ly6G antibodies to deplete neutrophil levels before infection with virulent S. Typhimurium (see Fig. S5B ). As shown in Fig. 7D , neutrophil depletion resulted in a 10-fold increase in mLN colonization of FAK-deficient mice compared to IgG-treated animals. As expected, anti-Ly6G treatment in WT animals did not impact bacterial burdens (Fig. 7D) .
Together, these data demonstrate that the ability of S. Typhimurium to manipulate FAK activity attenuates the early innate immune response to oral Salmonella infection and contributes to the enhanced morbidity observed in WT animals.
DISCUSSION
Type I interferons (IFNs) control a diverse array of host immune responses to infection and can be induced through both TLRdependent and -independent mechanisms. While it is well established that type I interferons are protective in the context of antiviral immunity, the role that they play during bacterial infection is less clear and appears to depend on the bacterial species (48, 49) . For example, IFN-␤ expression has been shown to protect against Legionella pneumophila (50, 51) , Chlamydia trachomatis (52), group B streptococci, pneumococci, and Escherichia coli (27) , whereas it exacerbates the outcome of infection with Listeria monocytogenes (53) (54) (55) , Francisella novicida (56), or mycobacteria (57) . In the case of Salmonella, the induction of type I interferon and its role in infection appear to depend on the route of entry: systemic delivery of virulent S. Typhimurium elicits a robust type I IFN response that actually impairs control of the pathogen (58), whereas IFN-␤ is barely detectable in any tissue after oral infection of WT mice (59), a finding that we confirmed in this study. Moreover, experimental induction of IFN-␤ through injection of the TLR3 ligand poly(I:C) was found to be protective in the context of oral Salmonella infection, where it enhanced bacterial clearance and reduced systemic dissemination (43) . Together, these studies suggest that orally acquired Salmonella bacteria may in fact suppress type I IFNs in the intestinal mucosa as a novel virulence strategy.
Autophagy is directly linked to IFN-␤ production in the context of bacterial infection.
It is well recognized that autophagy and Atg proteins play a critical role in innate recognition of viruses and downstream cytokine responses during viral infection. Previous studies have determined that pharmacological inhibition of autophagy or Atg deficiency in plasmacytoid dendritic cells (pDCs) prevents the recognition of vesicular stomatitis virus (VSV) (22) , Sendai virus (23) , and human immunodeficiency virus type 1 (HIV-1) (60) through endosomal TLR7. In addition, TLR9-dependent production of type I IFN, but not proinflammatory cytokines, requires the Atg5 gene, indicating that a pathway involving Atg proteins is required for IRF7-dependent signals downstream of endosomal TLR9 (22) . Thus, in the context of certain viral infections, autophagy facilitates host recognition of infection via delivery of viral ligand to the appropriate TLRcontaining compartment. However, a similar mechanism for bacterial IFN induction has not yet been described.
We have previously shown that Salmonella contained within SCVs inhibit autophagy by activating the FAK-Akt-mTOR pathway, which prevents cell-autonomous bacterial killing (20) . In the current study, we set out to determine whether this active suppression of autophagy also limits the availability of microbial degradation products capable of stimulating pattern recognition receptors and the induction of a type I interferon response. We show that conditions that promote autophagy (rapamycin treatment or FAK deficiency) significantly enhance IFN-␤ production, while suppression of autophagy through bacterially mediated FAK-AktmTOR signaling, pharmacological inhibition, or knockdown of essential autophagy components impairs the IFN-␤ response to Salmonella.
Furthermore, we found that IFN-␤ expression in autophagic macrophages is dependent on both TLR3 and TLR4 signaling but not on MyD88, MAVS, or STING. This is consistent with the requirement for the adapter protein TRIF, which is used exclusively by endosomal TLR3 and TLR4 to activate TBK1/IRF-3. On the basis of these observations, we propose that the autophagic panel a) , Salmonella bacteria activate the FAK-Akt-mTOR signaling pathway to suppress autophagy. Intracellular survival is enhanced, and in the absence of an IFN response, bacteria disseminate. In autophagic macrophages (panel b), Salmonella bacteria are captured and degraded in autophagosomes. Autophagy promotes the delivery of antigenic material to TLR-containing endosomes (see also Fig. 4H) , which activates the TRIF-IRF-3 pathway to induce the production of IFN-␤. IFN-␤ activates NK cells and promotes the production of IFN-␥. The presence of IFN-␥ is able to activate additional phagocytes as well as stimulate the production of CXC chemokines. CXCL9 and CXCL10 help recruit neutrophils to the site of infection and further prevent the dissemination of bacteria. degradation of Salmonella releases both LPS and nucleic acids into the autolysosomal lumen, where they contact TLR3 and TLR4. In support of this hypothesis, we found that neutralization of endosomal pH impaired both IRF-3 activation and IFN production. In contrast, the induction of autophagy alone by rapamycin in the absence of bacteria was not sufficient to activate TBK1 or IRF3 or stimulate IFN-␤ production (see model in Fig. 4) .
Manipulation of IFN signaling as a virulence strategy. It should be noted that all of the in vitro data described above were obtained using a noninvasive strain of S. Typhimurium, the ⌬invG mutant, which lacks a key component of the SPI1 T3SS. We used this strain to mimic the in vivo context, in which the SPI1 machinery is downregulated during transit across the intestinal epithelium (4, 29, 30) .
However, we cannot rule out the possibility that some Salmonella bacteria are still able to actively invade macrophages in a SPI-1-dependent manner to induce type I IFN. Nonetheless, our in vitro and in vivo data suggest that by targeting FAK signaling via SPI-2, Salmonella-mediated suppression of the interferon response functions as an important means of survival.
To confirm that suppression of interferon production is a relevant virulence strategy in vivo, we infected mice orally with WT S. Typhimurium (SL1344). As noted above, we found that oral infection induced barely detectable IFN-␤ expression in WT mice, whereas it was robust in FAK ⌬myeloid animals. Together with our in vitro data, this observation suggests that by targeting FAK signaling via SPI-2, Salmonella-mediated suppression of the interferon response functions as an important mechanism for survival. In agreement with this hypothesis, we found that experimental induction of IFN-␤ with poly(I:C) (61) provides significant protection against oral Salmonella infection, whereas blockade of the type I interferon receptor IFNAR1 leads to increased colonization of intestinal tissues and mLNs.
The striking protective ability of IFN-␤ may be mediated by its immunomodulatory effect on other cell types within intestinal tissues. Previous studies have shown that IFN-␤ promotes the induction of IFN-␥ in bystander NK cells (43, 62) , which we also observed in the current study. IFN-␥ is one of the most potent immunomodulatory cytokines expressed by cells, playing a critical role in antiviral, antibacterial, and antitumor responses, and functions as a bridge between innate immunity and adaptive immunity (63). Here we found that blocking IFN-␥, similarly to IFNAR1 blockade, increases bacterial burden in the ileum and mLNs, phenocopying the Salmonella sensitivity previously seen in interleukin-15 Ϫ/Ϫ (IL-15 Ϫ/Ϫ ) animals lacking NK cells and in IFN-␥ Ϫ/Ϫ animals (64) (65) (66) .
Another important aspect of the interferon response is the ability of these cytokines to activate and recruit additional leukocytes to sites of infection. In particular, CXCL9 and CXCL10 are macrophage early response genes induced in response to IFN-␥ (67) that function as potent chemoattractants for T cells, NK cells, and neutrophils (68) . The upregulation of both IFN-␤ and IFN-␥ in the intestinal tissues of infected FAK ⌬myeloid animals correlated with increased expression of CXCL9 and CXCL10 and enhanced recruitment of neutrophils into the mLNs. It is well known that cell-mediated immunity, especially the early recruitment of neutrophils, plays a critical role in Salmonella clearance (47, 69) . In line with this, we show that neutrophil depletion in FAK-deficient mice resulted in a significant increase in bacterial burden. Collectively, our findings suggest that enhanced survival of FAK ⌬myeloid animals is the result of an elevated early interferon-mediated local immune response accompanied by rapid neutrophil recruitment, which limits Salmonella dissemination from the intestine and mLNs.
On the basis of these observations, we propose an integrated working model whereby the autophagic capture of Salmonella enhances both cell-autonomous microbicidal activity (direct microbial killing in autolysosomes [20] ) and more-systemic mechanisms of bacterial killing initiated by the production of IFN-␤ (see model in Fig. 7) . In WT macrophages, activation of the Salmonella SPI-2 machinery specifically inhibits these responses through recruitment of FAK to the SCV. However, if autophagy is not suppressed, release of bacterial degradation products leads to activation of endosomal TLR3 and TLR4. Activation of endosomal TLRs then recruits the TRIF adapter, resulting in the activation of TBK1 and IRF-3 and the production of IFN-␤. IFN-␤ can act in an autocrine manner to induce the expression of interferonresponsive genes in macrophages and in a paracrine manner to enhance the production of IFN-␥ from local NK cells. IFN-␥ not only enhances the microbicidal activity of local phagocytes but also induces expression of the potent chemoattractants CXCL9 and CXCL10. The presence of CXC chemokines recruits additional innate immune cells, such as neutrophils and monocytes, thereby preventing the dissemination of Salmonella bacteria that may have escaped cell-autonomous killing.
MATERIALS AND METHODS
Ethics statement. All experiments in this study were performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. Protocols were approved by the Institutional Animal Care and Use Committee at the University of Virginia (Protocol no. 3488). All efforts were made to minimize animal suffering during the course of these studies.
Mice. The generation of myeloid-specific conditional FAK knockout mice and their control littermates has been described previously (20) . Mice were kept under pathogen-free conditions and were allowed free access to food and water.
Bacterial strains and culture. Salmonella Typhimurium strain SL1344 and the isogenic ⌬invG (SPI-1-deficient) invasion mutant have been described previously (20) . Bacteria were grown under invasioninducing conditions as described by Lee and Falkow (1990) (70) .
Infection of mice and experimental procedures. Animals were fasted for 3 to 4 h before oral-gastric infection with 1 ϫ 10 9 CFU of Salmonella Typhimurium strain SL1344/mouse. Mice were sacrificed 2 to 5 days postinfection, and the bacterial load in the PPs, mLN, cecum, and ileum (without PPs) was determined by plating serial dilutions of homogenized tissue suspensions on McConkey agar supplemented with 50 g/ml of streptomycin. For some experiments, mice were administered 250 g/ mouse of monoclonal antibody (MAb) anti-IFNAR1 (MAR1-5A3), antiLy6G (1A8), anti-IFN-␥ (XMG1.2), or IgG controls (MOPC-2 and 2A3), all purchased from BioXcell, via intraperitoneal (i.p.) injection 1 day prior to infection with SL1344. Poly(I:C) (100 g/mouse) was also delivered by i.p. injection 1 day before infection with SL1344.
Gentamicin resistance assay. Cells were seeded at 1 ϫ 10 5 to 2 ϫ 10 5 cells/well onto 24-well culture dishes 18 h prior to infection. For some experiments, macrophages were treated with 5 g/ml poly(I:C) (Sigma). Cells were then infected in complete media without antibiotics at a multiplicity of infection (MOI) of 100 for 30 min with the ⌬invG mutant diluted in Hanks' buffered sterile saline (HBSS). Infected cells were then either lysed directly (to establish total levels of cell-associated bacteria) or treated with gentamicin (Gibco) at a concentration of 100 g/ml for 30 min before lysis (to establish internalized bacteria), or medium was replaced with 1 g/ml gentamycin for a further 2 h. Cells were then lysed in 0.2% Triton X-100 -HBSS. CFU were enumerated by plating aliquots of lysates onto LB agar. To determine internalized percentages, the number of CFU internalized was divided by the total number of associated CFU. To determine percent survival, the number of CFU surviving at the end of the assay (3 h) was divided by the total number of CFU internalized.
Survival analysis and DAI. To examine survival, animals were inoculated with 1 ϫ 10 8 CFU SL1344/mouse (90% lethal dose [LD 90 ]) and then monitored daily for clinical symptoms of disease as defined by the disease activity index (DAI) adapted from Owen et al. (71) . The DAI was calculated based on body weight, hair coat, eye discharge, activity, and posture. The total scores were determined as follows: change in weight, 0 (no change), 1 (Ͻ10% weight reduction), 2 (10% to 20%), or 3 (Ͼ20%); change in hair coat, 0 (normal, groomed), 1 (mildly rough), or 2 (very rough, ungroomed); change in eyes, 0 (normal), 1 (closed), or 2 (closed, discharge); change in activity, 0 (normal), 1 (activity with prodding), 2 (little activity with prodding), or 3 (immobile); change in posture, 0 (normal), 1 (hunched), or 2 (head on floor). Animals were sacrificed when total weight loss went below 20% or when they scored at the top of the range in 2 categories. , and B220 (RA3-6B2). Isotype controls included rat IgG1 conjugated to either FITC or PE. Anti-IFN-␤ was purchased from PBL Interferon Source. For cell sorting, single-cell suspensions were surface stained before collection using a FACSVantage SE Turbo Sorter (Becton, Dickinson). For intracellular cytokine staining, mice were i.p. injected with 500 g monensin (Sigma-Aldrich)/mouse 6 h before tissue harvest. Intracellular IFN staining was performed using a fixation and permeabilization kit (eBioscience). IFN-positive cells were gated for surface marker analysis. Cells were collected on a CyAn ADP LX cytometer (Beckman Coulter) using Summit acquisition software (Dako) and analyzed using FlowJo software (Tree Star). For gating strategies, see Fig. S4 in the supplemental material.
Antibodies. Immunoblot analyses were performed using the following antibodies: Atg5, ERK1/2, STAT1, STAT1p Y701 , STING, TBK, IRF-3, phospho-TBK, and phospho-IRF3 (all purchased from Cell Signaling). Actin (cytoskeleton), caspase-1 (eBioscience), FAK (Santa Cruz Biotechnology), TRIF (Abcam), and tubulin (Sigma) antibodies were purchased from the suppliers indicated.
RNA extraction and real-time PCR. RNA extractions were performed using an RNeasy minikit (Qiagen). Expression of the IFN-␤1 mRNA (interferon beta), IFN-␣6 (interferon alpha), MyD88 mRNA, and TLR3 mRNA in confluent macrophage cultures infected with the ⌬invG mutant (MOI, 100) or in untreated controls was quantified by real-time PCR. For some experiments, PEMs were pretreated with 1 nM rapamycin or 5 mM 3-MA (both purchased from Calbiochem) or with 100 nmol bafilomycin A1 (Sigma) for 1 h prior to infection. In other experiments, PEMs were treated with 100 ng/ml of Salmonella LPS (InvivoGen) before RNA isolation. Analysis was performed using Applied Biosystems-validated TaqMan primer-probe sets (ifnb1:Mm00439552_s1; ifna6:Mm01703458_s1; myd88:Mm00440338_m1; tlr3:Mm01207404_m1) and an ABI PRISM SDS7000 sequence detection system (Applied Biosystems). For reverse transcription, random hexamers (1 g) and 10 ng of total RNA were used in a final reaction volume of 20 l containing 200 units of SuperScript (Invitrogen). PCR was performed in triplicate for 40 cycles using 20% of the first-strand-synthesis volume in a total volume of 50 l that included 25 l of SYBR green master mix (Applied Biosystems) and a 250 nM final concentration of primers. The threshold cycle (⌬C T ) method was used to quantify all relative mRNA levels as described (ABI user guide 1997), using 18 S RNA as the reference and internal standard.
Cell culture. Peritoneal macrophages (PEMs) were isolated from mouse peritoneal lavage fluid using sterile phosphate-buffered saline (PBS) supplemented with 0.5% bovine serum albumin (BSA) and 2 mM EDTA. Bone marrow-derived macrophages (BMDMs) were isolated by flushing femurs and tibias with PBS containing 0.5% BSA and 2 mM EDTA. Both PEMs and BMDMs were seeded onto bacterial plates and cultured in alpha-minimal essential medium (alpha-MEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 10% L929-conditioned media as a source of colony stimulating factor-1 (CSF-1), and 1% penicillin/streptomycin (pen/strep). Bone marrow-derived dendritic cells (BMDC) were generated as previously described, with slight modifications (72) . Briefly, bone marrow cells removed from mouse femurs and tibias were cultured for 7 days in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4) (BD Biosciences), enriched for DCs by negative selection (StemCell Technologies). WT, TLR4 Ϫ/Ϫ , MAVS Ϫ/Ϫ , and MyD88/TRIF Ϫ/Ϫ immortalized macrophages (iMacs) were a kind gift from Jonathan Kagan (Harvard Medical School, Boston, MA) and were cultured in primary macrophage media. J774 macrophages were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% heat-inactivated FBS and 1% pen/ strep.
Cell preparation. For LP suspensions, small intestines were excised, flushed with PBS, cut into 0.5-cm segments, and placed in shaking buffer (HBSS, 5% FBS, 2 mM EDTA) with agitation for 15 min at 37°C to remove epithelial cells. LP pieces were then digested in HBSS containing 5% FBS and 1 mg/ml collagenase IV (Sigma) with agitation for 20 min at 37°C. For mLNs, tissue was isolated and digested in collagenase IV-containing buffer as described above. Tissues were pipetted into single-cell suspensions or pressed through a nylon mesh filter (BD Falcon). Blood was obtained by cardiac puncture and immediately diluted in PBS containing 4 mM EDTA before red blood cell (RBC) lysis. For magnetic bead separation, single-cell suspensions were washed and filtered before incubation with magnetically activated cell sorting (MACS) beads (Miltenti BioTeC) conjugated to anti-CD11b, anti-CD11c, or anti-Ly6G for 15 min at 4°C. Cell suspensions were then washed and passed through a MACS column per the manufacturer's instructions before analysis by flow cytometry or lysis and immunoblotting.
Western blotting. Cells were seeded at~1 ϫ 10 5 to 2 ϫ 10 5 cells/well onto 24-well culture dishes at 18 h prior to infection. For some experiments, macrophages were pretreated with rapamycin (1 nM). Cells were then rinsed twice with PBS and lysed in modified radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris [pH 7.4], 1% NP-40, 150 mM NaCl, 0.5% deoxycholate, 10% glycerol, 0.1% sodium dodecyl sulfate [SDS]) supplemented with 1 mM sodium vanadate, 50-mM sodium fluoride, and a cocktail of protease inhibitors (0.1-mM phenylmethylsulfonyl fluoride and 1 g/ml each of pepstatin, leupeptin, and antipain). Samples were loaded onto 10% SDS-polyacrylamide gels and probed using the indicated antibodies.
Microscopy. PEMs were plated on glass coverslips (Fisher) overnight before infection with the ⌬invG mutant (MOI, 100). At 30 min after infection, the medium was changed to include gentamicin (100 g/ml) to kill extracellular bacteria before replacement with media containing 1 g/ml gentamycin for the remainder of the assay. Cells were fixed with 4% paraformaldehyde, followed by blocking and permeabilization in 10% normal goat serum (NGS)-0.2% saponin-PBS. Primary and secondary antibodies were diluted in blocking buffer and incubated with samples for 30 min to 1 h at room temperature (RT). After being washed, coverslips were mounted using ProLong Gold anti-fade (Invitrogen). Coverslips were examined with a 60ϫ objective on an Olympus BX51 High Magnification microscope equipped with an Olympus DP70 digital camera. Images were acquired using ImagePro software (MediaCybernetics).
Measurement of cytokines. mLN and LP cell suspensions isolated from infected or naive mice were lysed in 0.1% Triton X-100 containing a protease inhibitor cocktail (Calbiochem) before brief homogenization at 4°C. Supernatants were collected, and levels of murine cytokines and chemokines were determined by the use of a Luminex bead system and read using a Luminex 100 IS system. siRNA nucleofection. siRNA oligonucleotides (100 ng) targeting murine Atg5, FAK, TRIF, MyD88, IRF3, STING, and nontargeting controls (Invitrogen) were nucleofected into macrophages using an Amaxa mouse macrophage Nucleofector kit (Lonza) per the manufacturer's instructions.
Statistical analysis. Kaplan-Meier survival curves were generated for infected mice. Analyses of viable CFU recovered from the tissues of infected animals were performed using the Mann-Whitney U test. Student's t test was used for the comparison of 2 independent groups. Two-way analysis of variance (ANOVA) with Tukey's multicomponent posttest was used for comparing 2 or more independent groups. All tests were performed with Prism (GraphPad Software), and a P value of Ͻ0.05 was considered statistically significant.
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